May 21, 2021 11:07 AM IST
The state also emphasised that it will “prioritise” frontline workers and priority groups such as cab drivers and bank officials.
- May 19, 2021 05:37 PM IST
By August, suggest some experts, the situation will ease. July is the crucial month when indigenous production of vaccines will go up, as will imports
- May 19, 2021 02:26 PM IST
As the debate on allowing vaccine exports in the face of local shortage gains momentum, senior officials across key ministries say companies are free to honour their contractual obligations and sell abroad if they have enough doses
- May 18, 2021 07:47 PM IST
However, the company hopes to begin deliveries of vaccine to COVAX and other countries by end of 2021.
- May 18, 2021 04:32 PM IST
The Central government, last week, increased the gap between Covishield vaccine doses to 12-16 weeks.
- May 17, 2021 05:22 PM IST
One of India's top vaccine experts Dr Gagandeep Kang spoke to Moneycontrol's Chandra R Srikanth on the Government's vaccination roadmap, why there should be central procurement, if it is advisable to take the second dose of Covishield after 12 weeks and why plasma therapy should be dropped. She also spoke about when the second wave of Coronavirus began to taper in India.
- May 17, 2021 03:25 PM IST
The National AEFI Committee found that till April 3, 26 incidents of potential thromboembolic cases (blood clotting) following the administration of the Covishield vaccine were reported in India, with a reporting rate of 0.61 cases/ million doses.
- May 16, 2021 10:51 PM IST
The Centre had on May 13 extended the gap between the first and second doses of Covishield vaccine to 12-16 weeks based on the recommendations by the COVID Working Group chaired by N K Arora.
- May 16, 2021 06:57 PM IST
The two jabs of the Serum Institute of India (SII)-manufactured Covishield vaccine were earlier administered at a gap of six-to-eight weeks.
- May 15, 2021 05:19 PM IST
Dr VK Paul's response to the controversy comes two days after the Centre, based on an expert panel's recommendation, increased the gap between two doses of Covishield vaccine from 6-8 weeks to 12-16 weeks.
- May 14, 2021 01:23 PM IST
During 16-31 May, 191.99 lakh doses of Covishield and Covaxin will be supplied to the States and UTs, free of cost.
- May 14, 2021 12:10 PM IST
In terms of Fauci’s estimated threshold (70 percent) for herd immunity, India might reach that goal by mid-November.
- May 14, 2021 10:34 AM IST
On India's decision to extend the gap between two Covishield doses, Dr Anthony Fauci said that it is a "reasonable approach".
- May 14, 2021 07:53 AM IST
Coronavirus India News Highlights: The cumulative number of COVID-19 vaccine doses administered inched closer to 18 crore, the Union Health Ministry said.
- May 13, 2021 06:22 PM IST
While some municipalities are, or will issue tenders to procure vaccines, others are directly talking to manufacturers. The smaller provinces seem to be depending on distribution by the central government.
- May 13, 2021 05:55 PM IST
Around 750 million doses of Covishield and 550 million doses of Covaxin would be available in the period between August and December, said Niti Aayog member Dr VK Paul.
- May 13, 2021 04:44 PM IST
The suggestion to increase the gap between two Covishield doses was made by the National Technical Advisory Group on Immunisation (NTAGI).
- May 13, 2021 12:09 PM IST
Currently, India is facing an acute nationwide shortage of the Covishield vaccine and Serum Institute is struggling to keep up with demand.
- May 12, 2021 08:15 PM IST
Maharashtra Health Minister Rajesh Tope has said COVID-19 vaccination for the 18-44 age group has been suspended temporarily due to vaccine shortage.
- May 11, 2021 04:52 PM IST
The cheapest option among all metro cities to get the jab at a private setup is at HN Reliance Hospital where you can get a dose of Covishield for Rs 700.
- May 10, 2021 01:15 PM IST
An Indigo regular flight carrying the Covishield vaccine landed at Cochin International Airport at 11.50 AM, a CIAL spokesman said.
- May 09, 2021 03:44 PM IST
Covaxin is developed by Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research and the National Institute of Virology
- May 06, 2021 05:46 PM IST
The new observations which Prof Haseltine pointed out have more chances to be correct as the new variants of COVID-19 may be currently racing through India’s tightly-packed population of 1.4 billion people.
- May 06, 2021 11:27 AM IST
What does the US decision to support an initiative at WTO for temporary waiver of patent protection for COVID-19 vaccines mean for India? Below is a primer.
- May 05, 2021 12:43 PM IST
Companies other than Bharat Biotech must be given contracts to manufacture the indigenously developed Covaxin in bulk. This is the time to open licensing to any company that wants to produce vaccines and for anyone who wants to take a jab, per doctors.